Mgr. Václav Šeda, Ph.D.
Junior researcher, Marek Mráz Research Group
Office: bldg. E35/281
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7500 |
---|---|
E‑mail: |
Total number of publications: 79
2023
-
Coculture model with CD40L, IL4 and IL21 for study chronic lymphocytic leukemia proliferation.
Year: 2023, type: Conference abstract
-
FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.
Year: 2023, type: Conference abstract
-
FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.
Year: 2023, type: Conference abstract
-
Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.
Year: 2023, type: Conference abstract
-
Inhibitors for treatment of hematological malignancies
Publisher: United States Patent and Trademark Office, state: United States, patent's number: US11648255B2, year: 2023
-
Mechanismy adaptace CLL buněk na léčbu BCR inhibitory.
Year: 2023, type: Conference abstract
-
Molecular response of chronic lymphocytic leukemia cells to targeted therapy.
Year: 2023, type: Conference abstract
-
Nekódující RNA v biologii maligních B lymfocytů.
Year: 2023, type: Conference abstract
-
The role of long non-coding RNAs in BCR-mediated CLL activation.
Year: 2023, type: Conference abstract
-
The role of long non-coding RNAs in the microenvironmental interactions of malignant B cells.
Year: 2023, type: Conference abstract